Stock comparison
Cellebrite DI
Fair Isaac
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CLBT
Cellebrite DI
Market cap
$3.29B
Sector
Technology
FICO
Fair Isaac
Market cap
$28.75B
Sector
Technology
Overall winner
Fair Isaac FICO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CLBT | FICO | Winner |
|---|---|---|---|
| Warren Buffett | 48D | 85A | FICO |
| Benjamin Graham | 62D | 88A | FICO |
| Philip Fisher | 60C | 85A | FICO |
| Peter Lynch | 34F | 70B | FICO |
| Joel Greenblatt | 51C | 94C | FICO |
| Charlie Munger | 49D | 91A | FICO |
| Terry Smith | 50D | 95A | FICO |
Side-by-side metrics
| Metric | CLBT | FICO |
|---|---|---|
| Market cap | $3.29B | $28.75B |
| P/E (TTM) | 44.5x | 33.8x |
| EV/EBIT | 47.7x | 30.9x |
| ROIC (TTM) | 10.02% | 53.2% |
| Gross margin | 84.2% | 84.16% |
| Net margin | 16.47% | 33.67% |
| Revenue CAGR 5y | 17.89% | 10.89% |
| EPS CAGR 5y | -10.56% | 18.48% |
| Debt / Equity | 0.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CLBT leads on
- Revenue CAGR 5y17.89%vs 10.89%+39%
FICO leads on
- EPS CAGR 5y18.48%vs -10.56%+157%
- Debt / Equity-vs 0.0x+103%
- Market cap$28.75Bvs $3.29B+89%
- ROIC (TTM)53.2%vs 10.02%+81%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.